Commentary: One size does not fit ALK-targeted therapy, local ablation of recurrence, and improved outcomes after resection of ALK-positive lung cancer
- PMID: 33220966
- DOI: 10.1016/j.jtcvs.2020.10.041
Commentary: One size does not fit ALK-targeted therapy, local ablation of recurrence, and improved outcomes after resection of ALK-positive lung cancer
Comment on
-
Prognostic impact and distinctive characteristics of surgically resected anaplastic lymphoma kinase-rearranged lung adenocarcinoma.J Thorac Cardiovasc Surg. 2022 Feb;163(2):441-451.e1. doi: 10.1016/j.jtcvs.2020.09.120. Epub 2020 Oct 8. J Thorac Cardiovasc Surg. 2022. PMID: 33131892
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
